BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21383290)

  • 1. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.
    Loprinzi CL; Reeves BN; Dakhil SR; Sloan JA; Wolf SL; Burger KN; Kamal A; Le-Lindqwister NA; Soori GS; Jaslowski AJ; Novotny PJ; Lachance DH
    J Clin Oncol; 2011 Apr; 29(11):1472-8. PubMed ID: 21383290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.
    Reeves BN; Dakhil SR; Sloan JA; Wolf SL; Burger KN; Kamal A; Le-Lindqwister NA; Soori GS; Jaslowski AJ; Kelaghan J; Novotny PJ; Lachance DH; Loprinzi CL
    Cancer; 2012 Oct; 118(20):5171-8. PubMed ID: 22415454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.
    Wolf SL; Barton DL; Qin R; Wos EJ; Sloan JA; Liu H; Aaronson NK; Satele DV; Mattar BI; Green NB; Loprinzi CL
    Support Care Cancer; 2012 Mar; 20(3):625-32. PubMed ID: 21479990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.
    Pachman DR; Dockter T; Zekan PJ; Fruth B; Ruddy KJ; Ta LE; Lafky JM; Dentchev T; Le-Lindqwister NA; Sikov WM; Staff N; Beutler AS; Loprinzi CL
    Support Care Cancer; 2017 Nov; 25(11):3407-3416. PubMed ID: 28551844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.
    Shinde SS; Seisler D; Soori G; Atherton PJ; Pachman DR; Lafky J; Ruddy KJ; Loprinzi CL
    Support Care Cancer; 2016 Feb; 24(2):547-553. PubMed ID: 26155765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).
    Pachman DR; Qin R; Seisler D; Smith EM; Kaggal S; Novotny P; Ruddy KJ; Lafky JM; Ta LE; Beutler AS; Wagner-Johnston ND; Staff NP; Grothey A; Dougherty PM; Cavaletti G; Loprinzi CL
    Support Care Cancer; 2016 Dec; 24(12):5059-5068. PubMed ID: 27534963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study).
    Kuroi K; Shimozuma K; Ohashi Y; Hisamatsu K; Masuda N; Takeuchi A; Aranishi T; Morita S; Ohsumi S; Hausheer FH
    Support Care Cancer; 2009 Aug; 17(8):1071-80. PubMed ID: 19089463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial.
    Ruddy KJ; Le-Rademacher J; Lacouture ME; Wilkinson M; Onitilo AA; Vander Woude AC; Grosse-Perdekamp MT; Dockter T; Tan AD; Beutler A; Loprinzi CL
    Breast; 2019 Dec; 48():89-97. PubMed ID: 31590108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).
    Boora GK; Kulkarni AA; Kanwar R; Beyerlein P; Qin R; Banck MS; Ruddy KJ; Pleticha J; Lynch CA; Behrens RJ; Züchner S; Loprinzi CL; Beutler AS
    J Neurol Sci; 2015 Oct; 357(1-2):35-40. PubMed ID: 26143528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
    Jin L; Zhang Y; Yang W
    Int J Gynaecol Obstet; 2020 Jun; 149(3):303-308. PubMed ID: 32133643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
    Tawfik B; Dayao ZR; Brown-Glaberman UA; Pankratz VS; Lafky JM; Loprinzi CL; Barton DL
    Support Care Cancer; 2023 Oct; 31(12):637. PubMed ID: 37847317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing.
    Forsyth PA; Balmaceda C; Peterson K; Seidman AD; Brasher P; DeAngelis LM
    J Neurooncol; 1997 Oct; 35(1):47-53. PubMed ID: 9266440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel.
    Chen CS; Smith EML; Stringer KA; Henry NL; Hertz DL
    Breast Cancer Res Treat; 2022 Aug; 194(3):551-560. PubMed ID: 35760975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel.
    Reyes-Gibby CC; Morrow PK; Buzdar A; Shete S
    J Pain; 2009 Nov; 10(11):1146-50. PubMed ID: 19595634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.
    Flatters SJ; Xiao WH; Bennett GJ
    Neurosci Lett; 2006 Apr; 397(3):219-23. PubMed ID: 16406309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
    Khalefa HG; Shawki MA; Aboelhassan R; El Wakeel LM
    Breast Cancer Res Treat; 2020 Aug; 183(1):117-125. PubMed ID: 32601973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).
    Tanioka H; Nagasaka T; Uno F; Inoue M; Okita H; Katata Y; Kanzaki H; Kuramochi H; Satake H; Shindo Y; Doi A; Nasu J; Yamashita H; Yamaguchi Y
    BMC Cancer; 2019 Oct; 19(1):941. PubMed ID: 31604467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.
    Ventzel L; Jensen AB; Jensen AR; Jensen TS; Finnerup NB
    Pain; 2016 Mar; 157(3):560-568. PubMed ID: 26529271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.
    Sánchez-Barroso L; Apellaniz-Ruiz M; Gutiérrez-Gutiérrez G; Santos M; Roldán-Romero JM; Curras M; Remacha L; Calsina B; Calvo I; Sereno M; Merino M; García-Donas J; Castelo B; Guerra E; Letón R; Montero-Conde C; Cascón A; Inglada-Pérez L; Robledo M; Rodríguez-Antona C
    Oncologist; 2019 Aug; 24(8):e784-e792. PubMed ID: 30470691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance).
    Boora GK; Kanwar R; Kulkarni AA; Abyzov A; Sloan J; Ruddy KJ; Banck MS; Loprinzi CL; Beutler AS
    Cancer Med; 2016 Apr; 5(4):631-9. PubMed ID: 26763541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.